Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: The first report from Iran

International Journal of STD and AIDS

Volumn 25, Issue 6, 2014, Pages 420-427

  Mehrjerdi, Zahra Alam ^a   Abarashi, Zohreh ^b   Noroozi, Alireza ^c   Arshad, Leila ^d   Zarghami, Mehran ^e,f  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Sarzamin Khorshid Female Specific Drop in Centre   (Iran)

^e MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AIDS; high risk behaviours; HIV; injecting drug use; methamphetamine; sexual risk; sexually transmitted infections; shared injection

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; CONDOM USE; DEMOGRAPHY; DRUG USE; FEMALE; HEALTH PROGRAM; HEALTH STATUS; HELP SEEKING BEHAVIOR; HIGH RISK BEHAVIOR; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAN; MAJOR CLINICAL STUDY; MALE; PREVENTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; VIRUS INFECTION;

AIDS; HIGH RISK BEHAVIOURS; HIV; INJECTING DRUG USE; METHAMPHETAMINE; SEXUAL RISK; SEXUALLY TRANSMITTED INFECTIONS; SHARED INJECTION;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDOMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRAN; LOGISTIC MODELS; MALE; METHAMPHETAMINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE SHARING; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; QUESTIONNAIRES; RISK-TAKING; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84899695141     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462413512806     Document Type: Article

References (34)

1. Colfax G,Shoptaw S.The methamphetamine epidemic: implications for HIV prevention and treatment.Curr HIV/AIDS Rep. 2005;2:194-199.
2. Alam Mehrjerdi Z.Crystal in Iran: methamphetamine or heroin Kerack.Daru. 2013;21:1-3.
3. UNODC (United Nations Office on Drugs and Crime). World Drug Report. Vienna, Austria: UNODC, www.unodc.org/documents/./WDR2012/WDR_2012_web_small.pdf (2012, accessed 11 July 2012).
4. Alam Mehrjerdi Z,Noroozi A.An emerging trend of methamphetamine injection in Iran: a critical risk for blood-borne infection diseases.Hepat Mon. 2013;13:e8154-e8154.
5. UNAIDS (Joint United Nations Program on HIV/AIDS). 2006 Report on the Global AIDS Epidemic: AUNAIDS 10th Anniversary Special Edition. Geneva, Switzerland: UNAIDS, www.popline.org/node/179746 (2006, 11 July 2012).
6. Halkitis PN,Parsons JT,Stirratt MJ.A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men.J Homosex. 2001;4:17-35.
7. Shoptaw S,Reback CJ.Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions.Addiction. 2007;102:130-135.
8. Alavi SM,Behdad F.Seroprevalence study of hepatitis C and hepatitis B virus among hospitalized intravenous drug users in Ahvaz, Iran (2002-2006).Hepat Mon. 2010;10:101-104.
9. Amin-Esmaeili M,Rahimi-Movaghar A,Razaghi EM, et al.Factors correlated with hepatitis C and B virus infections among injecting drug users in Tehran, IR Iran.Hepat Mon. 2012;12:23-31.
10. Zamani S,Ono-Kihara M,Ichikawa S, et al.Potential for sexual transmission of HIV infection from male injecting-drug users who have sex with men in Tehran, Iran.Sex Transm Dis. 2010;37:715-718.
11. Ramezani A,Mohraz M,Gchkar L.Epidemiologic situation of human immunodeficiency virus (HIV/AIDS patients) at a private clinic in Tehran, Iran.Arch Iran Med. 2006;9:315-318.
12. Zamani S,Kihara M,Gouya MM, et al.High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran.J Acquir Immune Defic Syndr. 2006;42:342-346.
13. Day C,Nassirimanesh B,Shakeshaft A, et al.Patterns of drug use among a sample of drug users and injecting drug users attending a general practice in Iran.Harm Reduct J. 2006;3:2-2.
14. Zamani S,Radfar R,Nematollahi P, et al.Prevalence of HIV/HCV/HBV infections and drug-related risk behaviors amongst IDUs recruited through peer-driven sampling in Iran.Int J Drug Policy. 2010;21:493-500.
15. Rafiey H,Narenjiha H,Shirinbayan P, et al.Needle and syringe among Iranian drug injectors.Harm Reduct J. 2009;6:21-21.
16. Razzaghi EM,Rahimi Movaghar ARapid assessment and response: Multi-center project on injection drug use. Tehran: WHO; 2003:.
17. McLellan AT,Kushner H,Metzger D, et al.The fifth edition of the Addiction Severity Index.J Subst Abuse Treat. 1992;9:199-213.
18. Hassannejad R,Kassaian N,Ataei B, et al.High risky behaviors among intravenous drug users in Isfahan, Iran: a study for hepatitis C harm reduction programs.Int J Prev Med. 2012;:S73-S78.
19. HIV-associated behaviors among injecting-drug users-23 cities, United States, May 2005-February 2006.MMWR Morb Mortal Wkly Rep. 2009;58:329-332.
20. Rusch ML,Lozada R,Pollini RA, et al.Poly drug use among IDUs in Tijuana, Mexico: correlates of methamphetamine use and route of administration by gender.J Urban Health. 2009;86:760-777.
21. Hagan H,Campbell JV,Thiede H, et al.Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior.Drug Alcohol Depend. 2007;91:S48-S55.
22. Shaw SY,Shah L,Jolly AM, et al.Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.Addiction. 2007;102:1626-1635.
23. MacRae R,Aalto E.Gendered power dynamics and HIV risk in drug-using sexual relationships.AIDS Care. 2000;12:505-15.
24. Higgs P,Owada K,Hellard M, et al.Gender, culture and harm: an exploratory study of female heroin users of Vietnamese ethnicity.Cult Health Sex. 2008;10:681-695.
25. Des Jarlais DC,Perlis TE,Stimson GV, et al.WHO Phase II Drug Injection Collaborative Study Group: using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II.BMC Public Health. 2006;6:54-54.
26. Spittal PM,Craib KJ,Wood E, et al.Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.CMAJ. 2002;166:894-899.
27. Wood E,Spittal PM,Kerr T, et al.Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention.Can J Public Health. 2003;94:355-359.
28. Semple SJ,Grant I,Patterson TL.Female methamphetamine users: social characteristics and sexual risk behavior.Women Health. 2004;40:35-50.
29. Schwarcz S,Scheer S,McFarland W, et al.Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men.Am J Public Health. 2007;97:1067-1075.
30. Semple S,Patterson T,Grant I.The context of sexual risk behavior among heterosexual methamphetamine users.Addict Behav. 2004;29:807-810.
31. Rusch ML,Lozada R,Polloni RA, et al.Polydrug use among IDUs in Tijuana, Mexico: correlates of methamphetamine use and route of administration by gender.J Urban Health. 2009;86:760-775.
32. Greenwell L,Brecht ML.Self-reported health status among treated methamphetamine users.Am J Drug Alcohol Abuse. 2003;29:75-104.
33. McCoy CB,Inciardi JSex, drugs, and the continuing spread of AIDS. Los Angeles, CA: Roxbury Publishing Co; 1995:.
34. Todd Korthuis P,Feaster DJ,Gomez ZL, et al.Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness.Addict Behav. 2012;37:552-555.